While visiting Mumbai, American influencer Liz (Instagram handle @spicygori) called a diagnostic centre to schedule a routine blood test. She expected the usual trip to a lab, but was told a technician would come to her residence, collect the sample in roughly five minutes, and leave.

Unexpected Free Doorstep Service

Liz noted that the base price of the test was already about one‑tenth of what she would have paid in the United States. Assuming the clinic would recoup the difference through a doorstep‑service surcharge, she was stunned to learn that no extra fee was charged at all—hence her caption, “Only possible in India.”

Cost‑Effective Model of Indian Healthcare

Home phlebotomy has become a common offering among private Indian labs, emphasizing patient convenience, rapid turnaround, and low‑cost operations. Compared with U.S. pricing, routine blood panels in India are typically 70‑90 % cheaper, driven by locally manufactured generic reagents, lower overhead, and a highly competitive market.

Implications for Global Medical Tourism

Liz’s post, now viewed by over 1.8 million people, has amplified interest in India as a medical‑tourism hub. The combination of affordable, reliable services and a growing network of accredited facilities makes the country attractive for procedures ranging from routine diagnostics to complex oncology treatments.

Challenges and Opportunities Ahead

While the price advantage is clear, regulators must ensure quality control, data privacy, and patient safety keep pace with rapid expansion. Proper oversight could cement India’s reputation for cost‑effective yet high‑quality healthcare, influencing policy discussions worldwide.